Educational reference only. Nothing on this page constitutes medical advice or encourages personal use of this compound. Always consult a qualified healthcare provider before any decision involving your health.

Kisspeptin-10

KP-10 · Metastin 45-54 · Kisspeptin-10

Animal replicated

Research chemicalKisspeptin GnRH Axis Peptide Decapeptide

RouteInjectableGray-market only

Evidence grade: Animal replicated

Effect demonstrated in multiple animal studies; human data sparse or extrapolated. Grades summarize evidence quality, not whether a compound is appropriate, legal, or risk-free.

At a glance

What it is: KP-10 / Metastin45-54 / Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂ — Kisspeptin, GnRH Axis Peptide, Decapeptide.
Why people use it: Used primarily for hormonal support and sexual health.
What the evidence supports: The C4 audit for kisspeptin yields genuinely interesting findings — this is not a compound with incidental behavioral effects but one with documented, fMRI-confirmed effects on limbic brain processing specifically related to sexual motivation and emotional bonding.

If you only read one thing

Kisspeptin-10 sits at the apex of the HPG axis — the most upstream endogenous regulator of GnRH pulsatility ever identified, with grade A evidence that it stimulates LH, testosterone, and GnRH pulse frequency in healthy men, and clinical trial evidence across HH, hypothalamic amenorrhea, IVF triggering, and hypoactive sexual desire disorder. The community uses it primarily for PCT — specifically to address the hypothalamic level of HPG axis recovery that hCG (Leydig cell level) and SERMs (pituitary level) do not directly target. This PCT application has compelling mechanistic support and zero controlled human trial data. Community users are self-administering a potent hypothalamic neuropeptide that can produce either HPG stimulation or, if dosed incorrectly (too frequently), complete hypothalamic suppression equivalent to medical castration. The gap between pharmacological position and clinical evidence is wider than for almost any other community-used peptide in this reference.

Check interactions →

Published literature

5human RCTs1human study3animal2in vitro

Counts include controlled kisspeptin infusion studies for LH/GnRH stimulation, hypothalamic amenorrhea, IVF triggering, and sexual/limbic response; post-AAS PCT use has no controlled human trial.

Evidence reality check

Human evidence

6 human studies

5 randomized; 1 observational.

Preclinical base

5 lab signals

3 animal; 2 in-vitro/mechanistic.

Evidence snapshot

The C4 audit for kisspeptin yields genuinely interesting findings — this is not a compound with incidental behavioral effects but one with documented, fMRI-confirmed effects on limbic brain processing specifically related to sexual motivation and emotional bonding.

From the chapter quick-reference block.

Categories

Hormonal & HPTA Libido & Sexual Health

Properties

✓ Human RCT

Half-life

longest half-life (~28 minutes IV)

Evidence

CAnimal replicated

The HPG Apex Position

Kisspeptin neurons — specifically KNDy neurons (kisspeptin/neurokinin B/dynorphin) in the arcuate nucleus of the hypothalamus — are the GnRH pulse generator: the primary upstream activators of GnRH neuron firing. KISS1R (GPR54) on GnRH neurons is the receptor. Kisspeptin → KISS1R → Gq/11 signaling → PLC activation → IP3 → intracellular Ca²⁺ release → dramatic, sustained GnRH secretion. The consequence of sitting at this position: kisspeptin is the apex of the HPG axis; everything downstream (GnRH → LH/FSH → testosterone/ovulation) follows from kisspeptin signaling. Loss-of-function mutations in KISS1 or KISS1R cause complete hypogonadotropic hypogonadism — failure to enter puberty — proving the pathway is obligatory in humans.

The Origin Story — Named After Hershey's Kisses

The KISS1 gene was isolated in 1996 by Danny Welch's laboratory at the Hershey Medical Center in Hershey, Pennsylvania — the home of Hershey's Kisses chocolate. The gene was first characterized as a metastasis suppressor — a gene whose expression prevented cancer cells from undergoing metastasis. The kisspeptin name was coined as a nod to the geographic origin. The reproductive function was discovered 5 years later: in 2001, kisspeptin was identified as the endogenous ligand for the orphan receptor GPR54. In 2003, three simultaneous landmark papers demonstrated that loss-of-function mutations in GPR54 (KISS1R) cause hypogonadotropic hypogonadism — the pathway is obligatory for puberty and reproduction.

Clinical Trial Evidence — Strong in Reproductive Medicine

KP-10 and KP-54 have been studied in multiple human clinical trials. George 2011 (JCEM): KP-10 stimulates 2.5x LH increase and increases GnRH pulse frequency in healthy men. Jayasena et al.: pulsatile kisspeptin administration restores LH pulsatility in hypothalamic amenorrhea (multiple RCTs). IVF trigger: multiple RCTs showing KP-54 as safe, effective IVF trigger with lower OHSS risk vs hCG. Comninos 2017 (J Clin Invest): kisspeptin enhances limbic brain activity to sexual and bonding stimuli in healthy men by fMRI. Mills 2023 (JAMA Network Open): kisspeptin improved penile tumescence and sexual brain processing in men with HSDD. Thurston 2022 (JAMA Network Open): kisspeptin effects in women with HSDD. Grade A-B evidence across multiple clinical domains.

PCT Application — The Most Compelling Unproven Use

The PCT rationale for kisspeptin: after anabolic steroid cycles, the HPG axis is suppressed at all three levels — hypothalamus (no GnRH), pituitary (no LH), testes (dormant Leydig cells). Standard PCT (hCG + SERM) addresses pituitary and testicular levels but does not specifically address hypothalamic GnRH pulse generator restoration. Kisspeptin directly stimulates the hypothalamic GnRH pulse generator — the level that hCG and SERMs do not address. A kisspeptin-based PCT phase before or alongside SERMs is mechanistically compelling as the most upstream HPG axis restart available. No controlled human trial has evaluated this use. Grade D-E evidence for PCT specifically. Community use is experimental.

The Tachyphylaxis Problem

KISS1R undergoes desensitization with continuous agonist exposure — a property that is well-established and clinically critical. Continuous kisspeptin infusion paradoxically suppresses LH secretion (because KISS1R downregulates, GnRH neurons desensitize, and GnRH pulsatility collapses). This is equivalent to continuous GnRH agonist-induced medical castration. Pulsatile administration — discrete bolus doses separated by adequate washout intervals — is essential to avoid tachyphylaxis and maintain LH stimulation. Incorrect dosing frequency (too frequent) produces the opposite of the intended effect.

Simple view

Need the deep dive?

The default page keeps the decision layer visible first: summary, routes, evidence, and risks. Open the full report for mechanisms, chapter sections, citations, updates, and print/share controls.

Alternatives

Compare nearby options

Browse this class Compare 4 side by side →

Gonadorelin

Same class · Decapeptide

The Nobel Prize Decapeptide (Schally and Guillemin, 1977). The Compound That Is Stimulatory When Pulsatile and Suppressive When Continuous — From the Same Receptor. The Most Pharmacologically Nuanced Chapter in this reference. Why the FDA's March 2020 HCG Compounding Ban Changed TRT Practice Overnight. Gonadorelin vs HCG: The Fertility Preservation Head-to-Head. Why FSH Matters for Spermatogenesis. The Pulsatile Dosing Problem in Practice.

Enclomiphene

Shared goal · hormonal

The Pure Active Isomer in Clomid. The Drug That Raised Testosterone as Well as TRT While Preserving Fertility — and Still Failed FDA Approval. The Zuclomiphene Problem: Why the Racemic Mixture Causes Side Effects Pure Enclomiphene Shouldn't. The NDA That Died in 2021. How It Differs from TRT, HCG, and Gonadorelin for Male Hypogonadism. The 2025 Meta-Analysis: +273 ng/dL Testosterone vs Placebo.

Human Chorionic Gonadotropin